HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this...
View ArticleAllergan acquires Zeltiq Aesthetics in $2.48B deal
Allergan (NYSE:AGN) said today that it will pay $2.48 billion for Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting system uses a...
View ArticleAllergan closes $2.4B Zeltiq acquisition
Allergan (NYSE:AGN) said today that it closed its $2.48 billion acquisition of Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting...
View ArticleZeltiq handed FDA clearance for fat reduction device
Zeltiq landed 510(k) clearance from the Food & Drug Administration for its fat reducing device. The Pleasanton, Calif. based medical device developer’s CoolSculpting system works by cooling flabby...
View ArticleBoston University lands $13.6M to study cancer detection tools | Funding Roundup
Boston University School of Medicine landed a $13.6 million grant from the U.S. Defense Dept. lung cancer research program to study technologies focused on the early detection of lung cancer. The...
View ArticleGoldman pans Wall Street’s med-tech estimates
Wall Street’s overall take on sales and earnings forecasts for medical device makers this year is too high, according to Goldman Sachs (NYSE:GS) analyst David Roman, who sees The Street’s 4th-quarter...
View ArticleHeart docs claim harassment for exposing poor patient care | Legal News
Drs. Singh and Ihnken A group of California cardiologists filed a lawsuit against Santa Clara Valley Medical Center, alleging that they were harassed out of their jobs after they complained about a...
View ArticleGMI Ratings adds Boston Scientific to risky bet list | Wall Street Beat
A rating agency specializing in evaluating risky investments added Boston Scientific (NYSE:BSX) to its "Risk List," citing the ongoing fallout from its ill-starred Guidant buyout, its accounting and...
View ArticleSt. Jude Medical rebounds after “Greek tragedy”| Wall Street Beat
Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.” STJ shares closed down 3.3% yesterday at $39.96 when the company...
View ArticleBiolase CEO Pignatelli touts $1 salary | Earnings Roundup
Biolase Technology (NSDQ:BLTI) CEO Federico Pignatelli agreed to another year at a $1 salary as the dental laser maker met Wall Street’s 4th-quarter forecast with a whopping 35% top-line bump....
View ArticleEx-Stryker CEO MacMillan earned $9.5M in 2011 | Personnel Moves
Stryker’s (NYSE:SYK) former CEO, Stephen MacMillan, walked away from a pay package worth more than $9.5 million last year, SEC filings show. MacMillan’s pay included more than $1.3 million in salary,...
View ArticleImaging3 loses director, president & COO Sohn | Personnel Moves
Imaging3 (OTC:IMGG) president & COO resigned "to pursue other interests," according to a regulatory filing, leaving the mobile fluoroscopy device maker without a replacement. Sohn, whose...
View ArticleJ&J veteran Donald Casey takes helm of medical segment at Cardinal Health |...
Cardinal Health appointed Donald Casey Jr. to lead its $9 billion medical products and services division, effective next week. Casey is a 24-year Johnson & Johnson (NYSE:JNJ) veteran, starting in...
View ArticleCardioInsight chief Arless replaced by 2-man “office of the president”|...
CardioInsight chairman & CEO Steve Arless resigns, to be replaced by 2-man "office of the president" CardioInsight Technologies chairman & CEO Steve Arless resigned suddenly, to be replaced...
View ArticleEdwards CEO Mussallem announces stock plans | Personnel Moves
Edwards’ CEO Mussallem exercises stock options Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem will this month begin exercising stock options that were nearing expiration through...
View ArticleUniversity of Michigan sues St. Jude Medical for breach of contract
The University of Michigan is suing St. Jude Medical (NYSE:STJ), accusing the medical device maker of failing to pay $4.3 million in royalties on sales of St. Jude’s Epic and Trifecta cardiovascular...
View ArticleMako Surgical shareholders file 6 lawsuits in 4 months after stock dives
Mako Surgical (NSDQ:MAKO) shareholders have filed 6 lawsuits in the last 4 months, accusing the company of misstating the company’s sales and financial outlook in order to artificially inflate its...
View ArticleBy the numbers: The aesthetic medical device market picks up during the 2nd...
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn’t necessarily translate into healthy bottom...
View ArticleZeltiq makes it official with interim CEO | Personnel Moves
Zeltiq seals the deal with interim CEO Zeltiq (NSDQ:ZLTQ) appointed Mark Foley the official president & CEO, a position he’s held on an interim basis since former president & CEO Gordie Nye...
View ArticleWeight-loss: Zeltiq Aesthetics launches new CoolCurve applicator for...
California-based medical technology company Zeltiq (NSDQ:ZLTQ) launched CoolCurve+, a new applicator platform for its CoolSculpting system to help physicians to "treat more body shapes." Unlike...
View ArticleAccuray details new CEO appointment | Personnel Moves
Accuray details new CEO’s position California-based medical device maker Accuray (NSDQ:ARAY) earlier this month announced Joshua Levine, aged 54, as its new president & CEO following the...
View ArticleSpanish court denies Zeltiq, Mass. General in patent suit against Clinipro
Zeltiq (NSDQ:ZLTQ) said the Mercantile Court in Spain denied its bid for a preliminary injunction against Clinipro in a joint lawsuit filed with Mass. General Hospital against the French medical...
View Article
More Pages to Explore .....